Siddharth Bhatia

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis

William J. Sandborn, Filip Baert, Silvio Danese et al. · Gastroenterology · 2019 · 317 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn’s Disease: Results From the VISIBLE 2 Randomised Trial

Séverine Vermeire, Geert D’Haens, Filip Baert et al. · Journal of Crohn s and Colitis · 2021 · 170 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study

Jeffrey S. Hyams, Dan Turner, Stanley A. Cohen et al. · Journal of Crohn s and Colitis · 2022 · 45 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for <i>Helicobacter pylori</i> eradication

Ki Young Huh, Hyewon Chung, Yu Kyong Kim et al. · British Journal of Clinical Pharmacology · 2021 · 42 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Comparative proteomics of geographically distinct saw-scaled viper (Echis carinatus) venoms from India

Siddharth Bhatia, Karthikeyan Vasudevan · Toxicon X · 2020 · 34 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16